Article Versions Notes

Angelico G, Broggi G, Caltabiano R, Santoro A, Spadola S, D’Alessandris N, Scaglione G, Valente M, Arciuolo D, Sanchez AM, et al. Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer. Applied Sciences. 2021; 11(15):6788. https://doi.org/10.3390/app11156788

Angelico, Giuseppe, Giuseppe Broggi, Rosario Caltabiano, Angela Santoro, Saveria Spadola, Nicoletta D’Alessandris, Giulia Scaglione, Michele Valente, Damiano Arciuolo, Alejandro Martin Sanchez, and et al. 2021. "Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer" Applied Sciences 11, no. 15: 6788. https://doi.org/10.3390/app11156788

Angelico, G., Broggi, G., Caltabiano, R., Santoro, A., Spadola, S., D’Alessandris, N., Scaglione, G., Valente, M., Arciuolo, D., Sanchez, A. M., Franceschini, G., Masetti, R., Mulè, A., & Zannoni, G. F. (2021). Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer. Applied Sciences, 11(15), 6788. https://doi.org/10.3390/app11156788